No need to go over to Ihub. There is no intelligent life over there, just pumpers and dumpers and short scammers. But odds are your grand kids will never see a dime from biomatrix or Regen unless the company can find funds to run clinical trials. So far, the company has had no luck. Is it any wonder why it delayed the hemaxellerate trial unitl the third quarter? And even then no guarantee they will get it going then. It appears that the new president Landers has his head screwed on better than the CEO but still, funding OTC biotechs is not easy,especially in today's climate. Why don't you lend Regen some of your vast wealth to run the trials?